Latest filings (excl ownership)
6-K
Innate Pharma Announces Advancement Of Sanofi-Developed Nk Cell Engager Sar443579 / Iph6101 Progressing To Phase 2 For Blood Cancer Patients
15 Apr 24
6-K
Current report (foreign)
15 Apr 24
6-K
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
10 Apr 24
20-F
2023 FY
Annual report (foreign)
4 Apr 24
6-K
Summary of Consolidated Financial Statements and Notes
21 Mar 24
6-K
Innate Pharma reports Full Year 2023 Financial Results and Business Update
21 Mar 24
6-K
Innate Pharma Announces Its Participation To Upcoming Investor Conference
19 Mar 24
6-K
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
14 Mar 24
6-K
Current report (foreign)
6 Mar 24
6-K
Current report (foreign)
6 Mar 24
6-K
Innate Pharma Announces Its Participation To Upcoming Investor Conference
21 Feb 24
6-K
Current report (foreign)
6 Feb 24
424B5
Prospectus supplement for primary offering
6 Feb 24
EFFECT
Notice of effectiveness
17 Jan 24
6-K
Innate Pharma S.a. 6-K
12 Jan 24
CORRESP
Correspondence with SEC
11 Jan 24
6-K
Innate Pharma S.a. 6-K
5 Jan 24
6-K
FDA lifts partial clinical hold on lacutamab clinical programFatal case related to disease progression and unrelated to the treatment
4 Jan 24
6-K
Innate Pharma 6-K
4 Jan 24
UPLOAD
Letter from SEC
26 Dec 23
F-3
Shelf registration (foreign)
20 Dec 23
6-K
Current report (foreign)
20 Dec 23
6-K
Innate Pharma S.a. 6-K
19 Dec 23
6-K
Innate Pharma S.a. 6-K
18 Dec 23
6-K
Innate Pharma S.a. 6-K
11 Dec 23
6-K
Innate Pharma S.a. 6-K
11 Dec 23
6-K
Innate Pharma S.a. 6-K
27 Nov 23
6-K
Innate Pharma S.a. 6-K
14 Nov 23
6-K
Innate Pharma S.a. 6-K
7 Nov 23
6-K
Innate Pharma S.a. 6-K
3 Nov 23
6-K
Innate Pharma S.a. 6-K
27 Oct 23
6-K
Innate Pharma S.a. 6-K
19 Oct 23
6-K
Innate Pharma S.a. 6-K
16 Oct 23
6-K
Innate Pharma S.a. 6-K
10 Oct 23
6-K
Innate Pharma S.a. 6-K
5 Oct 23
6-K
Innate Pharma S.a. 6-K
22 Sep 23
6-K
Innate Pharma Reports First Half 2023 Financial Results and Business Update
14 Sep 23
6-K
Innate Pharma S.a. 6-K
14 Sep 23
6-K
Innate Pharma S.a. 6-K
29 Aug 23
6-K
Innate Pharma S.a. 6-K
10 Aug 23